Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Craig Brooks-Rooney"'
Autor:
Chen-Hua Liu, Ming-Lung Yu, Cheng-Yuan Peng, Tsai-Yuan Hsieh, Yi-Hsiang Huang, Wei-Wen Su, Pin-Nan Cheng, Chih-Lin Lin, Ching-Chu Lo, Chi-Yi Chen, Jyh-Jou Chen, Qian Ma, Craig Brooks-Rooney, Jia-Horng Kao
Publikováno v:
Journal of the Formosan Medical Association, Vol 118, Iss 6, Pp 1014-1023 (2019)
Background/Purpose: While direct-acting antiviral regimens have been approved for chronic hepatitis C (CHC) patients in Taiwan, reimbursement is limited to certain populations. Thus, pegylated interferon plus ribavirin (PEG-IFN/RBV) remains the stand
Externí odkaz:
https://doaj.org/article/daef8329372b4c10aaf0cc4a4b621cef
Autor:
Won-Mook Choi, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, W. Ray Kim, Leland J. Yee, Craig Brooks-Rooney, Tristan Curteis, Harriet Cant, Chien-Hung Chen, Chi-Yi Chen, Yi-Hsiang Huang, Young-Joo Jin, Dae Won Jun, Jin-Wook Kim, Neung Hwa Park, Cheng-Yuan Peng, Hyun Phil Shin, Jung Woo Shin, Yao-Hsu Yang, Young-Suk Lim
Publikováno v:
Journal of hepatology.
Comparative risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) receiving tenofovir disoproxil fumarate (TDF) versus entecavir (ETV) remains controversial. This individual patient data (IPD) meta-analysis aimed to compar
Autor:
Won-Mook Choi, Terry Cheuk-Fung Yip, Grace Wong, W.Ra Kim, Leland Yee, Craig Brooks-Rooney, Tristan Curteis, Harriet Cant, Chien-Hung Chen, Chi-Yi Chen, Yi-Hsiang Huang, Young-Joo Jin, Dae Won Jun, Jin-Wook Kim, Neung Hwa Park, Cheng-Yuan Peng, Hyun Phil Shin, Jungwoo Shin, Yao-Hsu Yang, Young-Suk Lim
Publikováno v:
Journal of Hepatology. 77:S870-S871
Autor:
Jia-Horng Kao, Tsai Yuan Hsieh, Ming-Lung Yu, Ching Chu Lo, Cheng Yuan Peng, Craig Brooks-Rooney, Wei Wen Su, Jyh Jou Chen, Chen-Hua Liu, Pin-Nan Cheng, Chi Yi Chen, Yi Hsiang Huang, Qian Ma, Chih-Lin Lin
Publikováno v:
Journal of the Formosan Medical Association, Vol 118, Iss 6, Pp 1014-1023 (2019)
Background/Purpose: While direct-acting antiviral regimens have been approved for chronic hepatitis C (CHC) patients in Taiwan, reimbursement is limited to certain populations. Thus, pegylated interferon plus ribavirin (PEG-IFN/RBV) remains the stand
Autor:
Craig Brooks-Rooney, Hiroshi Yatsuhashi, Masayuki Kurosaki, Alvin Ng, Mindie H. Nguyen, I-Heng Lee, Hiroshi Yotsuyanagi
Publikováno v:
Digestive diseases (Basel, Switzerland). 40(1)
Introduction: Advancing age, comorbidity, and financial burden have been observed in chronic hepatitis B (CHB) patients globally. As Japan is leading the world in aging demographics, similar real-world data are urgently needed for its CHB population
Autor:
Ching Chu Lo, Ming-Lung Yu, Pin-Nan Cheng, Craig Brooks-Rooney, Yi Hsiang Huang, Cheng Yuan Peng, Chen-Hua Liu, Jyh Jou Chen, Tsai Yuan Hsieh, Wei Wen Su, Chi Yi Chen, Jia-Horng Kao, Chih-Lin Lin, Qian Ma
Publikováno v:
Alimentary Pharmacology & Therapeutics. 48:1290-1300
Background While direct-acting antivirals have been approved for treating hepatitis C, the guidelines highlight the importance of considering potential drug-drug interactions between DAAs and concomitant medications. Aim To assess comorbidity prevale
Autor:
Zobair M. Younossi, Francesco Negro, Atsushi Tanaka, Craig Brooks-Rooney, Yuichiro Eguchi, Ming-Lung Yu, Norifumi Kawada, Yock Young Dan, Mario U. Mondelli, Young-Suk Lim
Publikováno v:
Liver International, Vol. 37, No 2 (2017) pp. 159-172
Between 80 and 115 million people worldwide are chronically infected with hepatitis C virus, with 60%-90% of these being undiagnosed. Untreated chronic hepatitis C (CHC) is associated with progressive liver disease, cirrhosis, hepatocellular carcinom
Autor:
Choi, Won-Mook, Yip, Terry Cheuk-Fung, Wong, Grace Lai-Hung, Kim, W. Ray, Yee, Leland J., Brooks-Rooney, Craig, Curteis, Tristan, Clark, Laura J., Jafry, Zarena, Chen, Chien-Hung, Chen, Chi-Yi, Huang, Yi-Hsiang, Jin, Young-Joo, Jun, Dae Won, Kim, Jin-Wook, Park, Neung Hwa, Peng, Cheng-Yuan, Shin, Hyun Phil, Shin, Jung Woo, Yang, Yao-Hsu, Lim, Young-Suk
Publikováno v:
In Clinical Gastroenterology and Hepatology
Autor:
Liu, Chen‐Hua1, Yu, Ming‐Lung2, Peng, Cheng‐Yuan3, Hsieh, Tsai‐Yuan1, Huang, Yi‐Hsiang1, Su, Wei‐Wen3, Cheng, Pin‐Nan4, Lin, Chih‐Lin1, Lo, Ching‐Chu5, Chen, Chi‐Yi5, Chen, Jyh‐Jou4, Ma, Qian6, Brooks‐Rooney, Craig6, Kao, Jia‐Horng1 kaojh@ntu.edu.tw
Publikováno v:
Alimentary Pharmacology & Therapeutics. Dec2018, Vol. 48 Issue 11/12, p1290-1300. 11p. 4 Charts, 5 Graphs.
Autor:
Younossi, Z. M.1,2 zobair.younossi@inova.org, Chan, H. L. Y.3, Dan, Y. Y.4, Lee, M. H.5, Lim, Y. S.6, Kruger, E.7, Tan, S. C.7
Publikováno v:
Journal of Viral Hepatitis. Mar2018, Vol. 25 Issue 3, p228-235. 8p.